These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5435359)

  • 1. Lymphocyte cytotoxic antibodies in systemic lupus erythematosus.
    Mittal KK; Rossen RD; Sharp JT; Lidsky MD; Butler WT
    Nature; 1970 Mar; 225(5239):1255-6. PubMed ID: 5435359
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on antilymphocyte antibodies in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Winchester RJ; Winfield JB; Fu SM; Wernet P; Kunkel HG
    Rheumatology; 1975; 6():209-14. PubMed ID: 1081726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymphocytotoxic antibodies in autoimmune diseases].
    Klingelhöfer HL; Malchow H; Havemann K; Börngen U
    Verh Dtsch Ges Inn Med; 1972; 78():884-7. PubMed ID: 4665773
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocyte function in rheumatic disorders.
    Vaughan JH; Chihara T
    Arch Intern Med; 1975 Oct; 135(10):1324-8. PubMed ID: 1100001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytes' cytotoxicity towards cells of human lymphoblastoid lines in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Skurkovich SV; Skorikova AS; Dubrovina NA; Riabova TV; Eremkina EI; Golodnenkova VN; Klinova EG; Olshanski AJ; Shurlapova NF
    Ann Allergy; 1977 Nov; 39(5):344-50. PubMed ID: 921001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-DNA binding activity in systemic lupus erythematosus, rheumatoid arthritis, and normal subjects.
    Pottgen P; Salvatore R
    Clin Chem; 1979 Jul; 25(7):1342-3. PubMed ID: 455665
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of interleukin-2 on peripheral lymphocytes and monocytes. III. Proliferative and cytotoxic effects in vitro in patients with systemic erythematosus and progressive polyarthritis].
    Jíra M; Strejcek J; Zavadil Z; Antosová E; Rejholec V
    Cas Lek Cesk; 1988 Dec; 127(52):1609-12. PubMed ID: 3265892
    [No Abstract]   [Full Text] [Related]  

  • 8. Abnormal populations of activated lymphocytes in the rheumatoid one-way MLR.
    Salmon M; Bacon PA
    Agents Actions; 1986 Dec; 19(5-6):269-70. PubMed ID: 3825744
    [No Abstract]   [Full Text] [Related]  

  • 9. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.
    Winchester RJ; Winfield JB; Siegal F; Wernet P; Bentwich Z; Kunkel HG
    J Clin Invest; 1974 Nov; 54(5):1082-92. PubMed ID: 4138924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid factor and antinuclear antibody in systemic lupus erythematosus, rheumatoid arthritis and infectious mononucleosis.
    Ichida CK; Yokoyama M
    Hawaii Med J; 1971; 30(3):170-3. PubMed ID: 4105320
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lymphocyte transformation during immunosuppressive therapy of lupus erythematosus visceralis].
    Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:152-4. PubMed ID: 5402572
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum antibodies to gangliosides in systemic lupus erythematosus.
    Neisser A; Gatterbauer B; Graninger W; Menschik M; Bernheimer H
    Ann N Y Acad Sci; 1997 Aug; 823():300-2. PubMed ID: 9292057
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantitative evaluation of the immunoglobulin-synthesizing function of the peripheral lymphocytes in rheumatoid arthritis, systemic lupus erythematosus and rheumatism].
    Benenson EV; Panov VG; Seĭsenbaev ASh; Sagandykov BB
    Ter Arkh; 1982; 54(6):37-40. PubMed ID: 6810488
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibodies against autologous lymphocytes in lupus erythematosus].
    Michlmayr G; Asamer H; Huber C; Huber H
    Klin Wochenschr; 1972 May; 50(9):484-6. PubMed ID: 5043473
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies.
    Horwitz DA; Garrett MA; Craig AH
    Clin Exp Immunol; 1977 Jan; 27(1):100-10. PubMed ID: 849643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-fixing ability of antinuclear factors. Studies in adult and juvenile rheumatoid arthritis and systemic lupus erythematosus.
    Cossio PM; Arana RM; Morteo OG; Hübscher O; Roux EB
    Ann Rheum Dis; 1971 Nov; 30(6):640-4. PubMed ID: 5316115
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-immunological characteristics of rheumatoid arthritis and systemic lupus erythematosus].
    Mikunis RI; Kozlova TV
    Ter Arkh; 1983; 55(7):46-9. PubMed ID: 6623383
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged thoracic-duct drainage in rheumatoid arthritis and systemic lupus erythematosus.
    Paulus HE; Machleder HI; Clements PJ; Nyman K; Levine S
    West J Med; 1979 Apr; 130(4):309-24. PubMed ID: 375588
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibodies to antinuclear subsets in systemic lupus erythematosus and rheumatoid arthritis.
    Smolen JS; Hassfeld W; Graninger W; Steiner G
    Clin Exp Rheumatol; 1990; 8 Suppl 5():41-4. PubMed ID: 2245525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological studies on the nature of anemia in rheumatoid arthritis and leukopenia in systemic lupus erythematosus.
    Sugimoto M; Wakabayashi Y; Shiokawa Y; Takaku F
    Ryumachi; 1981; 21 Suppl():51-60. PubMed ID: 7344136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.